Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
J.ReddyM
A 2025 preliminary safety study administered intravenous BPC-157 to 2 participants at escalating doses with no adverse effects reported, but the extremely limited sample size prevents meaningful conclusions
The positive rat result on CRF-induced corticosterone release (PMID 2995861) sits directly against the negative human result on CRH- and meal-induced ACTH and cortisol (PMID 7777652)
It is important to note that these strategies are not meant to prevent, mitigate, treat or cure hyperthyroidism and shouldnt be confused as such
Peptide therapy requires product-specific medical evaluation, informed consent, and appropriate follow-up
However, like all research peptides, it must be used only in non-human laboratory settings , and should never be promoted or interpreted as a therapeutic product
US$ 22.92
US$ 22.46
US$ 27.13
